Near future
No Result
View All Result
February 4 2023
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+
Understand, anticipate, improve the future.
CES2023 / Coronavirus / Russia-Ukraine
Near future
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+

Understand, anticipate, improve the future.

No Result
View All Result
Medicine

A urine test can detect bladder cancer 10 years earlier

A massive cohort study confirmed an important role that a biomarker has in detecting bladder cancer early. Off to further studies.

READ THIS IN:

EN CN FR DE JA PT RU ES
Share146Pin4Tweet12SendShare3ShareShare2
February 21 2020
Gianluca RiccioGianluca Riccio
⚪ 3 minutes

A compelling new study from WHO's International Agency for Research on Cancer (IARC) suggests that a simple biomarker in urine could be an effective predictive test for bladder cancer, signaling the presence of the disease up to 10 years before it appears. clinical signs.

Bladder cancer is a type of cancer that needs to be caught in its early stages. The best diagnostic technique currently available is an invasive imaging procedure called cystoscopy.

There are currently several biomarkers to be detected in the urine being studied, but none have been clinically verified enough to be widely recommended. And even in that case they are effective tools only in the control of active cases and in detecting the first signs of the disease.

Bladder cancer, the role of genetics

For several years, researchers have known that mutations in the reverse telomerase transcriptase (TERT) gene are incredibly common in many cases of bladder cancer. These TERT mutations can be detected in urine samples, but until now it was unclear whether this biomarker was an effective early detection tool.

The study on TERT mutations

To investigate this possibility, IARC scientists collaborated with a team of Iranian researchers working on a long-term research project called Cohort study Golestan.

The article continues after the related links

Take a seat: the AI ​​doctors will visit you soon

Avatar motion capture used to study genetic disorders

Not always the potential benefits against cancer they are accidentally found. Rather. In this case the planning was painstaking.

The project, which started in 2004, recruited over 50.000 healthy subjects for a long-term study. At the beginning of the project, a bank of biological samples was created: blood, urine, hair and nails. This provided the researchers with a valuable basis for study.

"We collected urine samples from 50.045 Iranian individuals and followed up with a follow-up of over 10 years. This research is one of the few population-based research that offers the opportunity to evaluate urinary biomarkers for clinical detection of bladder cancer." . He explains it Reza Malekzaded, coauthor and principal responsible for the Golestan cohort study.

Bladder cancer, the co-author of the Golestan cohort study
Reza Malekzaded

In the end, 38 people developed bladder cancer from the study group and TERT mutations were detected in 46,7% of these subjects. Perhaps more importantly, no TERT mutations were detected in a control group of 152 subjects without cancer.

"Our results provide the first evidence on the potential for TERT promoter mutations. It is a promising non-invasive biomarker for early detection of bladder cancer." says Ismail Hosen, another author of the study.

As always, I recommend caution

The researchers admit that this is an initial pilot study. The cohort of subjects with bladder cancer is still small, 38 people are not many. For this reason, the predictive nature of TERT mutations will still have to be verified before approaching clinical use.

However, this is an extraordinarily promising test, simple and cheap for bladder cancer. If validated in larger studies, it could offer doctors a valuable new tool to catch this tumor in its early stages.

The new research was published in the EbioMedicine magazine.

Tags: biomarkerscancerBladder cancerdiagnosesUrine

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff

Most read in the week

  • 'AI lawyer' to assist client in a lawsuit: first time in the world

    1368 Shares
    Share 547 Tweet 342
  • I tested for you GPTZero, the weapon against the invasion of automatic texts.

    442 Shares
    Share 176 Tweet 110
  • Akio Toyoda has an idea: instead of new cars, we convert existing ones

    369 Shares
    Share 147 Tweet 92
  • Giant wind turbines like skyscrapers, a new study makes them possible

    315 Shares
    Share 126 Tweet 79
  • 27 jobs that will disappear within 50 years

    2836 Shares
    Share 1134 Tweet 709

Enter the Telegram channel of Futuroprossimo, click here. Or follow us on Instagram, Facebook, Twitter, Mastodon e LinkedIn.

The daily tomorrow.


Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

FacebookTwitterInstagramTelegramLinkedInMastodonPinterestTikTok
  • Environment
  • Architecture
  • Artificial intelligence
  • Gadgets
  • concepts
  • Design
  • Medicine
  • Spazio
  • Robotica
  • Work
  • Inland solutions
  • Energy
  • Edition Francaise
  • Deutsche Ausgabe
  • Japanese version
  • English Edition
  • Portuguese Edition
  • Русское издание
  • Spanish edition

Subscribe to our newsletter

  • The Editor
  • Advertising on FP

© 2022 Near future - Creative Commons License
This work is distributed under license Creative Commons Attribution 4.0 International.

No Result
View All Result
Understand, anticipate, improve the future.
  • Home
  • Tech
  • Health
  • Environment
  • Energy
  • Inland solutions
  • Spazio
  • AI
  • concepts
  • H+